CA1134275A - Amino acid solutions for patients with cancers - Google Patents

Amino acid solutions for patients with cancers

Info

Publication number
CA1134275A
CA1134275A CA334,841A CA334841A CA1134275A CA 1134275 A CA1134275 A CA 1134275A CA 334841 A CA334841 A CA 334841A CA 1134275 A CA1134275 A CA 1134275A
Authority
CA
Canada
Prior art keywords
amino acid
cancer
solution
solutions
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA334,841A
Other languages
English (en)
French (fr)
Inventor
Koji Ozeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Factory Inc
Application granted granted Critical
Publication of CA1134275A publication Critical patent/CA1134275A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA334,841A 1978-09-04 1979-08-31 Amino acid solutions for patients with cancers Expired CA1134275A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient
JP108749/78 1978-09-04

Publications (1)

Publication Number Publication Date
CA1134275A true CA1134275A (en) 1982-10-26

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
CA334,841A Expired CA1134275A (en) 1978-09-04 1979-08-31 Amino acid solutions for patients with cancers

Country Status (10)

Country Link
JP (1) JPS5535049A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU526207B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1134275A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH642541A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2935709C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2434622A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2029220B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1194844B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL190266C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE448679B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003552A1 (en) * 1981-04-17 1982-10-28 Hospital Supply Corp American Improved solution for parenteral nutrition
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
KR0172193B1 (ko) * 1991-10-07 1999-02-01 오오쓰까 아끼히꼬 암 치료용 경장제제
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
AU687768B2 (en) * 1992-11-19 1998-03-05 Anticancer, Inc. Use of methioninase as an antitumor agent in anti-methionine chemotherapy
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
RU2125874C1 (ru) * 1994-07-04 1999-02-10 Казанский государственный университет им.В.И.Ульянова-Ленина Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
WO1998004255A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
RU2144821C1 (ru) * 1999-02-16 2000-01-27 Товарищество с ограниченной ответственностью Фирма "ГЛЕС" Противоопухолевое средство
EP1163904B1 (en) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium
ES2261136T3 (es) * 2000-10-09 2006-11-16 Matthias Dr. Med. Rath Composicion terapeutica de ascorbato con lisina y arginina para prevencion y tratamiento del cancer.
CH694549A5 (de) 2001-01-16 2005-03-31 Dr Matthias Rath Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) * 2001-10-05 2005-02-10 哲朗 浅尾 免疫系活性化剤
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2005092097A1 (en) * 2004-03-19 2005-10-06 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
PL1909600T3 (pl) * 2005-07-29 2012-09-28 Tima Found Kompozycja spowalniająca metabolizm alkoholu i ograniczająca ryzyko chorób wywołanych alkoholem
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
US8211700B2 (en) 2007-03-28 2012-07-03 University Of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
CA2722365C (en) 2008-04-24 2019-08-06 University Of Southern California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
KR101919747B1 (ko) * 2011-02-17 2018-11-20 각꼬호우진 구루메 다이가쿠 화학요법제의 항종양 활성 증강제
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung

Also Published As

Publication number Publication date
JPS6154007B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-11-20
GB2029220A (en) 1980-03-19
IT7905216A0 (it) 1979-09-03
AU5036879A (en) 1980-03-13
DE2935709A1 (de) 1980-03-13
NL190266C (nl) 1994-01-03
GB2029220B (en) 1983-03-30
IT1194844B (it) 1988-09-28
DE2935709C2 (de) 1986-02-06
SE448679B (sv) 1987-03-16
JPS5535049A (en) 1980-03-11
CH642541A5 (de) 1984-04-30
FR2434622A1 (fr) 1980-03-28
NL7906620A (nl) 1980-03-06
NL190266B (nl) 1993-08-02
FR2434622B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-04-15
SE7907316L (sv) 1980-03-05
AU526207B2 (en) 1982-12-23

Similar Documents

Publication Publication Date Title
CA1134275A (en) Amino acid solutions for patients with cancers
US4499076A (en) Elemental diets for liver diseases
US5719119A (en) Parenteral nutrition therapy with amino acids
US6103748A (en) Method of treating an autoimmune disorder
EP0547099B1 (en) Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
EP0679081B1 (en) Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
EA025137B1 (ru) Раствор для диализа, включающий одно или более соединений креатина и способ его получения
WO1987003806A1 (en) Parenteral nutrition therapy with amino acids
US20050197398A1 (en) Therapeutic agent for hepatic disease
EP0227545B1 (en) Nutritional supplement for treatment of uremia
US4902718A (en) Calcium homeostasis compositions and methods for controlling calcium metabolism
D'Souza et al. Glutamine supplements in the critically ill
US6797729B1 (en) Therapeutic glutamine and N-actyl-cysteine composition
JPH0368514A (ja) 癌用アミノ酸製剤
CA2134380C (en) Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
Giordano et al. Effects of catabolic stress in acute and chronic renal failure
WO1985003002A1 (en) Parenteral nutrition with medium and long chain triglycerides
CA1334575C (en) Substitution fluid preparation comprising 3-hydroxybutyric acid (beta-hydroxybutyric acid) and its salts
EP0057209A1 (en) Novel amino acid preparation and therapy for treatment of stress and injury
AU651824B2 (en) Pharmaceutical composition
EP0076841A1 (en) Improved solution for parenteral nutrition
JP4187957B2 (ja) コリン配合輸液剤
AU580278B2 (en) Treating liver diseases in patients by administering compositions of medium and long chain triglycerides
KR20070085961A (ko) 발기 부전의 치료를 위한 아세틸 엘 카르니틴과 프로피오닐엘 카르니틴 및 실데나필과의 병용된 용도
Macdougall Nutrition, anaemia and erythropoietin therapy

Legal Events

Date Code Title Description
MKEX Expiry